Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs Naproxen in Juvenile Rheumatoid Arthritis
NCT00034853Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2000
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of meloxicam in juvenile idiopathic arthritis (JIA), sponsored by Boehringer Ingelheim. Started Dec 2000; status: completed.
02
Drugs
meloxicam
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT00034853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034853.